Patients in Bradford referred with suspected skin cancer are being seen and reassured more quickly thanks to the introduction of artificial intelligence technology, according to reports on the local NHS service.
The move is part of a growing trend across the health service, where AI tools are being used to help triage urgent skin cancer referrals â one of the fastest-growing sources of pressure on dermatology departments in England.
How the technology works
AI-assisted skin lesion assessment typically involves taking high-quality, standardised images of a mole or lesion, often using a specialist camera attachment fitted to a smartphone or a dedicated imaging device. The images are then analysed by software trained to recognise visual patterns associated with melanoma and other skin cancers.
Crucially, the technology is not used to make a final diagnosis on its own. Instead, it supports clinical decision-making: lesions flagged as potentially suspicious are escalated to a dermatologist for review, while those assessed as very low risk can be discharged more quickly, usually with a clinician signing off the outcome.
The practical effect is that patients who do not have cancer can be told so sooner, freeing up specialist appointments for those who genuinely need urgent face-to-face assessment and treatment.
Why waiting times matter
Skin cancer is among the most commonly diagnosed cancers in the UK, and urgent suspected cancer referrals for skin conditions have risen sharply in recent years. Dermatology departments nationally have struggled to keep pace, with limited numbers of consultants and rising demand creating bottlenecks in the two-week-wait pathway.
That backlog has two consequences. The first is clinical: delays in diagnosing melanoma can allow a treatable cancer to progress. Melanoma caught at an early stage is highly curable, but survival rates fall significantly if it spreads. The second is psychological â the weeks spent waiting for an appointment can be a period of intense anxiety for patients and their families, the vast majority of whom will ultimately be given the all-clear.
By speeding up the sorting process, AI triage aims to address both problems at once.
Part of a wider shift
Bradford is not alone. Several NHS trusts across England have adopted AI-supported dermatology pathways over the past few years, and the technology has been held up by health leaders as an example of how automation might help the service manage demand without a corresponding increase in staff numbers.
Supporters argue that image-based specialties such as dermatology, radiology and pathology are natural early candidates for AI assistance, because the underlying task â spotting patterns in pictures â is well suited to machine learning.
There is caution too. Clinicians and regulators have stressed the importance of robust oversight, ensuring that AI tools perform reliably across different skin tones and that a qualified human remains responsible for every clinical decision. Concerns about the risk of missed diagnoses mean most services build in safety nets, including the ability for patients to return if a lesion changes.
What patients should do
Health advice remains unchanged. Anyone who notices a new mole, or a change in the size, shape, colour or texture of an existing one â or a sore that does not heal â is encouraged to contact their GP. Early presentation remains the single most important factor in successful skin cancer treatment, whatever technology sits behind the scenes.
For patients in Bradford, the hope is that the answer, when it comes, now arrives rather sooner than it used to. Read More
Leave a Reply